+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Vegetarian Capsules - Global Strategic Business Report

  • PDF Icon

    Report

  • 469 Pages
  • August 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6107097
The global market for Vegetarian Capsules was estimated at US$1.9 Billion in 2024 and is projected to reach US$2.9 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Vegetarian Capsules market.

Global Vegetarian Capsules Market - Key Trends & Drivers Summarized

Why Are Vegetarian Capsules Preferred Across Health and Wellness Segments?

Vegetarian capsules are plant-derived alternatives to traditional gelatin capsules and are made primarily from cellulose-based polymers such as hydroxypropyl methylcellulose (HPMC) or fermented pullulan. These capsules provide a non-animal delivery format that meets the ethical, cultural, and dietary preferences of vegetarian, vegan, kosher, and halal consumers. Their neutral taste, absence of allergens, and compatibility with a wide range of active ingredients make them suitable for dietary supplements, functional foods, and botanical-based formulations. As ethical sourcing and ingredient transparency become mainstream, vegetarian capsules offer product developers a compliant solution for consumer-friendly labeling.

Unlike gelatin capsules, vegetarian options do not rely on animal-derived collagen and are thus free from BSE and TSE transmission concerns. This distinction is particularly important in health-conscious markets where ingredient origin and cross-contamination risks are scrutinized. Their suitability for heat-sensitive and moisture-sensitive contents further strengthens their role in clean-label nutraceuticals. Increasingly, pharmaceutical companies are exploring plant-based capsules for over-the-counter medications in response to growing demand for inclusive product design.

How Are Regulatory and Manufacturing Trends Supporting Product Standardization?

Regulatory compliance and third-party certifications have become essential in marketing vegetarian capsules across global markets. Formulators increasingly seek capsules certified by recognized vegan, halal, and kosher authorities to meet export and labeling requirements. This regulatory assurance is especially significant in markets with strict dietary laws or religious standards. Quality standards related to moisture content, shelf life, and oxygen permeability are also being refined to match the performance of traditional gelatin capsules.

Manufacturers are investing in automated capsule production technologies capable of handling plant-based films without compromising on encapsulation speed or accuracy. These upgrades are enabling cost-efficient scale-up and broader application across therapeutic segments. In addition, transparency in excipient sourcing and traceability are helping capsule suppliers address the growing preference for non-GMO, gluten-free, and allergen-free ingredient declarations. These regulatory and operational improvements are helping vegetarian capsules gain parity with gelatin-based systems in both efficacy and reliability.

What Innovations Are Enhancing the Versatility of Vegetarian Capsule Systems?

Product innovation is focused on expanding the functional scope of vegetarian capsules to support delayed-release, enteric-coated, and sustained-release dosage forms. Manufacturers are developing capsules that can withstand stomach acid and disintegrate in targeted sections of the digestive tract, improving the bioavailability of specific nutrients or active compounds. Acid-resistant and moisture-sealed capsule shells are particularly valuable for probiotic and enzyme formulations that require protection until they reach the small intestine.

Combination dosage forms, including dual-fill capsules and transparent-coated variants, are also being introduced to enhance visual appeal and performance differentiation. Capsules tailored for oil-based, powder, and granular fills are allowing supplement brands to diversify product offerings while adhering to vegetarian claims. Customization in size, color, and branding is helping nutraceutical companies align packaging aesthetics with brand identity. These capabilities are particularly important for direct-to-consumer supplement brands seeking to create shelf presence and reinforce premium positioning.

What Market-Specific Factors Are Driving Demand Across Segments and Regions?

Growth in the vegetarian capsules market is driven by several factors linked to consumer dietary patterns, certification requirements, and product innovation. Increasing demand for plant-based supplements and clean-label formulations across North America, Europe, and Southeast Asia is supporting the shift from gelatin to plant-derived capsules. Pharmaceutical companies are also exploring vegetarian capsules for inclusivity in patient demographics with cultural or ethical restrictions. Growth of probiotic, herbal, and functional supplement categories is reinforcing demand for acid-resistant and moisture-tolerant vegetarian capsule formats. Advancements in capsule shell materials, coupled with enhancements in production machinery, are improving scale-up feasibility and cost-efficiency. Additionally, regulatory push for clearer labeling and consumer interest in traceable, animal-free ingredients are compelling both contract manufacturers and supplement brands to prioritize vegetarian capsule adoption. Expansion of personalized nutrition and demand for combination-dose products is further strengthening the market position of vegetarian capsules across therapeutic and wellness applications.

Scope Of Study:

The report analyzes the Vegetarian Capsules market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Product (Hydroxypropyl Methyl Cellulose Capsules, Pullulan Vegetarian Capsules); Functionality (Immediate-Release Functionality, Sustained-Release Functionality, Delayed-Release Functionality); Application (Antibiotic & Antibacterial Drugs Application, Vitamin & Dietary Supplements Application, Anti-Inflammatory Application, Cardiovascular Therapy Application, Antacid & Antiaffluent Application); End-Use (Pharmaceuticals End-Use, Nutraceuticals End-Use, Contract Manufacturing Organizations End-Use, Cosmetics End-Use)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Hydroxypropyl Methyl Cellulose Capsules segment, which is expected to reach US$2.1 Billion by 2030 with a CAGR of a 9.0%. The Pullulan Vegetarian Capsules segment is also set to grow at 5.0% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $515.8 Million in 2024, and China, forecasted to grow at an impressive 12.2% CAGR to reach $634.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Vegetarian Capsules Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Vegetarian Capsules Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Vegetarian Capsules Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as ACG (Associated Capsules Pvt Ltd), Aenova Group, AlfaCaps LLC, Ashland Inc., Bright Pharma Caps and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 34 companies featured in this Vegetarian Capsules market report include:

  • ACG (Associated Capsules Pvt Ltd)
  • Aenova Group
  • AlfaCaps LLC
  • Ashland Inc.
  • Bright Pharma Caps
  • CapsCanada
  • Capsugel (Lonza Group)
  • Captek Softgel International Inc.
  • Catalent Inc.
  • Dow Chemical
  • Erkang
  • EuroCaps
  • Lotte Fine Chemical
  • Nouryon
  • QUALICAPS (Roquette Frères)
  • Robinson Pharma Inc.
  • Roquette Frères
  • Shandong Healsee Capsule Ltd.
  • Shin-Etsu Chemical Co., Ltd.
  • Sirio Europe GmbH

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Vegetarian Capsules - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Shift Toward Plant-Based and Ethical Supplement Formats Propels Long-Term Adoption of Vegetarian Capsules
  • Growing Demand for Animal-Free, Gelatin-Free Dosage Forms Drives Market Expansion Across Nutraceutical Applications
  • Increasing Consumer Awareness of Dietary Restrictions Strengthens Demand for Halal, Kosher, and Allergen-Free Capsules
  • Rapid Expansion of Vegan, Ayurvedic, and Herbal Supplement Markets Generates Opportunities for Vegetarian Capsule Manufacturers
  • Rising Scrutiny of Animal-Derived Ingredients and BSE-Related Concerns Accelerate Transition to Vegetarian Capsule Formats
  • Technological Advancements in HPMC and Pullulan Capsule Production Support Heat Stability and Fill Versatility
  • Preference for Clean-Label and Transparent Supplement Solutions Sustains Innovation in Additive-Free Capsule Shells
  • Surge in Preventive Healthcare and Wellness Routines Expands the Addressable Market for Daily Use Vegetarian Capsules
  • Aging Population Need for Gut-Friendly and Digestible Dosage Forms Reinforces Demand for Plant-Based Capsules
  • Expanding E-Commerce and DTC Nutraceutical Channels Increase Visibility and Sales of Certified Vegetarian Capsules
  • High Growth in Sports Nutrition, Cognitive Health, and Immune Support Segments Creates Cross-Sector Demand for Veg Capsules
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Vegetarian Capsules Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Hydroxypropyl Methyl Cellulose Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pullulan Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pullulan Vegetarian Capsules by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Pullulan Vegetarian Capsules by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Antacid & Antiaffluent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Antacid & Antiaffluent Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Antacid & Antiaffluent Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Antibiotic & Antibacterial Drugs Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Antibiotic & Antibacterial Drugs Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Antibiotic & Antibacterial Drugs Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Vitamin & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Vitamin & Dietary Supplements Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Vitamin & Dietary Supplements Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Anti-Inflammatory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Anti-Inflammatory Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Anti-Inflammatory Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cardiovascular Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Cardiovascular Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Pharmaceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Pharmaceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Nutraceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Nutraceuticals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Nutraceuticals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Contract Manufacturing Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Contract Manufacturing Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cosmetics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Cosmetics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Immediate-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Immediate-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Sustained-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Sustained-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Sustained-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Delayed-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Delayed-Release Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Delayed-Release Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Vegetarian Capsules Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ACG (Associated Capsules Pvt Ltd)
  • Aenova Group
  • AlfaCaps LLC
  • Ashland Inc.
  • Bright Pharma Caps
  • CapsCanada
  • Capsugel (Lonza Group)
  • Captek Softgel International Inc.
  • Catalent Inc.
  • Dow Chemical
  • Erkang
  • EuroCaps
  • Lotte Fine Chemical
  • Nouryon
  • QUALICAPS (Roquette Frères)
  • Robinson Pharma Inc.
  • Roquette Frères
  • Shandong Healsee Capsule Ltd.
  • Shin-Etsu Chemical Co., Ltd.
  • Sirio Europe GmbH

Table Information